MedPath

Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts

Phase 1
Completed
Conditions
Trophic Ulcer
Non-healing Wound
Non-Healing Ulcer of Skin
Interventions
Biological: Dermal fibroblasts
Device: LED phototherapy
Registration Number
NCT04483934
Lead Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Brief Summary

Treatment of patients with non-healing wounds and trophic ulcers using local LED phototherapy with local transplantation of autologous dermal fibroblasts

Detailed Description

During the implementation of the project, it was planned to develop a method for the treatment of trophic ulcers using injection of autologous dermal fibroblasts in the wound.

The positive outlook for the effectiveness of photodiode therapy with dermal fibroblasts is due to the following:

* the ability of fibroblasts to stimulate tissue regeneration

* positive results of preclinical studies of the method of treatment of long-term non-healing wounds in animals (rats).

Twelve patients were included in the study. Dermal fibroblasts were isolated from the skin patients, cultured and then transplanted back to the wound.

The therapeutic dose of cells was 50k per cm2 of the wound area. Follow up patients monitoring was performed at 1, 2 and more months after injection.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Trophic Ulcers
  • Chronic non-healing wounds
Exclusion Criteria
  • acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
  • mental disorders
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients treated with dermal fibroblastsLED phototherapyCultured dermal fibroblasts and LED phototherepy
Patients treated with dermal fibroblastsDermal fibroblastsCultured dermal fibroblasts and LED phototherepy
Primary Outcome Measures
NameTimeMethod
Number of patients with tropic ulcers cured1 month

Number of patients cured

Number of patients with treatment-related adverse events4 weeks

Fibroblasts injection related adverse events assessed by blood count and function tests

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

🇧🇾

Minsk, Belarus

© Copyright 2025. All Rights Reserved by MedPath